Consulate Health Care Of Brandon | |
701 Victoria St, Brandon, Florida 33510 | |
(813) 681-4220 | |
Name | Consulate Health Care Of Brandon |
---|---|
Location | 701 Victoria St, Brandon, Florida |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 90% |
Medicare ID (CCN) | 105520 |
Legal Business Name | Brandon Facility Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1194477661 |
Organization Name | BRANDON HEALTH OPCO, LLC |
Address | 701 Victoria St, Brandon, FL 33510 |
Phone Number | 813-681-4220 |
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
NPI Number | 1528479573 |
Address | 701 Victoria St, Brandon, FL 33510 |
Phone Number | 813-691-4220 |
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
NPI Number | 1609816057 |
Organization Name | OP BRANDON, INC. |
Doing Business As | TANDEM HEALTH CARE OF BRANDON |
Address | 701 Victoria St, Brandon, FL 33510 |
Phone Number | 813-681-4220 |
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
NPI Number | 1780606715 |
Organization Name | BRANDON FACILITY OPERATIONS LLC |
Doing Business As | RAYDIANT HEALTH CARE OF BRANDON |
Address | 701 Victoria St, Brandon, FL 33510 |
Phone Number | 813-681-4220 |
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 4 |
Total Amount of Fines in Dollars | $32335 |
Number of Payment Denials | 1 |
Total Number of Penalties | 5 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.69 | 14.46 |
Percentage of long-stay residents who lose too much weight | 9.17 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.83 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.28 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.8 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 1.12 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.37 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.88 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 5.58 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 86.69 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.33 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 58.77 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.01 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 13.42 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.25 | 95.98 |
Percentage of short-stay residents who made improvements in function | 61.48 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.32 | 82.93 |
News Archive
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.
Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer.
A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.
› Verified 6 days ago
Consulate Health Care Of Brandon Location: 701 Victoria St, Brandon, Florida 33510 Phone: (813) 681-4220 | |
Central Park Healthcare And Rehabilitation Center Location: 702 S Kings Ave, Brandon, Florida 33511 Phone: (813) 651-1818 | |
Hawthorne Health And Rehab Of Brandon Location: 851 West Lumsden Rd, Brandon, Florida 33511 Phone: (813) 661-8998 | |
Brandon Health And Rehabilitation Center Location: 1465 Oakfield Dr, Brandon, Florida 33511 Phone: (813) 655-0404 |